Dr. Jimita Toraskar from PubGene AS was invited to participate in the International Lecture Series organized by Dr. Bhanuben Nanavati College of Pharmacy in Mumbai,
The futureofhealth.care is an online discussion platform for healthcare professionals. It identifies white space in the market so that promising start-up and healthcare industry can
PubGene’s digital health platform for personalised medicine, Coremine Vitae, obtained the CE-mark Class I Medical Device, ensuring that it complies with all the relevant Essential Requirements of the Medical Devices Directive – 93/42/EEC MDD and subsequent amendments.
Innovation Norway – the State and the county authorities’ instrument for achieving value-creating business development – has allocated pre-project funds to PubGene to investigate how COREMINE Medical can be used to
PubGene has had dialogue with Norwegian health authorities on a possible role for establishing an information channel on the COVID-19 virus, with continuous update on
PubGene’s project proposal ‘Coremine Vitae: Realising the promise of precision medicine for cancer patients and their healthcare providers with biomedical intelligence reporting’ submitted for the European Innovation Council